ArticleACS medicinal chemistry letters2022

The Inhibitors of Protein Tyrosine Phosphatase Nonreceptor Type 2 (PTPN2) as Potential Enhancers of Cancer Immunotherapy and Type 1 (PTPN1) as Treatment of Metabolic Diseases.

Ahmed F Abdel-MagidPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.